Form 8-K AQUABOUNTY TECHNOLOGIES For: Apr 18
false000160397800016039782024-04-182024-04-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 18, 2024
AquaBounty Technologies, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-36426
04-3156167
(State or other jurisdictionof incorporation)
Form 8-K VAIL RESORTS INC For: Apr 19
false000081201100008120112024-04-192024-04-19UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934Date of report (Date of earliest event reported): April 19, 2024 Vail Resorts, Inc. (Exact Name of Registrant as Specified in Charter)Delaware001-0961451-0291762(State or Other Jurisdiction ofIncorporation or Organization)(Commission File Number)(I.R.S.... (continue reading...)
Form D/A Liberty Hall Capital NL
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form DEFA14A Jamf Holding Corp.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.   )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨Preliminary Proxy Statement
¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨Definitive Proxy Statement
More SEC Filings
View Older Stories-
Form DEFA14A Elanco Animal Health
-
Form DEF 14A Elanco Animal Health For: May 30
-
Form DEF 14A Jamf Holding Corp. For: May 30
-
Form DEF 14A INTERNATIONAL TOWER HILL For: May 29
-
Form DEF 14A PRIMEENERGY RESOURCES For: Jun 05
-
Form 8-K CUMULUS MEDIA INC For: Apr 18
-
Form 6-K Steakholder Foods Ltd. For: Apr 19
-
Form 20-F Concord Medical Services For: Dec 31
-
Form ARS Karyopharm Therapeutics For: Dec 31
-
Form D/A Chameleon Global Fund
-
Form D/A Chameleon Global Fund
-
Form DEFA14A NORFOLK SOUTHERN CORP
-
Form 8-K/A Ayala Pharmaceuticals, For: Mar 25
-
Form 6-K ICICI BANK LTD For: Apr 12
-
Form 6-K Baozun Inc. For: Apr 19
-
Form 424B3 Volato Group, Inc.
-
Form DEFA14A Karyopharm Therapeutics
-
Form S-4/A ORRSTOWN FINANCIAL SERVI
-
Form D/A Bergamot Music Fund I
-
Form 4 abrdn Global Infrastruct For: Apr 18 Filed by: Goodson Alan R
-
Form ARS Verrica Pharmaceuticals For: Dec 31
-
Form ARS FTI CONSULTING, INC For: Dec 31
-
Form MA-A UniBank Fiscal Advisory For: Dec 31
-
Form DEF 14A Karyopharm Therapeutics For: May 29
-
Form D/A Noetic Fund II (US), LP
-
Form DEFA14A Verrica Pharmaceuticals
-
Form DEFA14A Apartment Income REIT
-
Form DEFA14A FTI CONSULTING, INC
-
Form DEF 14A FTI CONSULTING, INC For: Jun 05
-
Form 8-K Apartment Income REIT, For: Apr 19 Filed by: Apartment Income REIT Corp.
-
Form DEF 14A Verrica Pharmaceuticals For: Jun 06
-
Form D/A FCOI II Currency Class
-
Form 6-K DR REDDYS LABORATORIES For: Apr 19
-
Form 6-K Baozun Inc. For: Apr 19
-
Form D/A Candriam Global Emerging
-
Form 8-K AMCON DISTRIBUTING CO For: Apr 18
-
Form 425 Global Partner Acquisiti Filed by: Global Partner Acquisition Corp II
-
Form PX14A6G KINDER MORGAN, INC. Filed by: NORGES BANK
-
Form ARS Allegion plc For: Dec 31
-
Form 8-K CUMULUS MEDIA INC For: Apr 18
-
Form DEFA14A Allegion plc
-
Form DEF 14A Allegion plc For: Jun 06
-
Form 6-K ProQR Therapeutics N.V. For: Apr 19
-
Form X-17A-5 MORGAN STANLEY & CO INTE For: Dec 31
-
Form 8-K AMERICAN EXPRESS CO For: Apr 19
-
Form 20-F Jianpu Technology Inc. For: Dec 31
-
Form 425 ChampionX Corp Filed by: SCHLUMBERGER LIMITED/NV
-
Form PRE 14A BioXcel Therapeutics, For: Jun 10
-
Form PRE 14A Entrada Therapeutics, For: Jun 13
-
Form 6-K Tiziana Life Sciences For: Apr 19